The Trump administration has asked a U.S. appeals court to reject an attempt by Delta Air Lines and Aeromexico to block a government order that requires them to dissolve their joint venture. The partnership, which allowed both airlines to coordinate flight schedules, pricing, and capacity between the U.S. and Mexico, has been under scrutiny for limiting competition in key international routes.
According to the U.S. Department of Transportation (DOT), the airlines’ collaboration effectively reduced competition by allowing two major carriers to control nearly 60% of all flights at Mexico City International Airport—one of the largest international gateways to and from the United States. The department stated that it “validly decided to no longer authorize legalized collusion by two formerly competing airlines,” emphasizing that the joint venture restricts fair market access for other airlines and limits consumer choice.
The order to unwind the agreement follows years of regulatory review and changing political stances on antitrust enforcement. Initially approved in 2016 under a previous administration, the joint venture was seen as a way to improve connectivity between the two nations. However, U.S. regulators now argue that market dominance by Delta and Aeromexico has resulted in higher fares and fewer competitive options for travelers.
Delta and Aeromexico have defended their partnership, stating that it benefits consumers through more flight options, better connections, and coordinated services. They argue that the DOT’s decision disregards the broader economic benefits of cross-border cooperation between the U.S. and Mexico.
The case underscores ongoing tensions between airline alliances and antitrust regulators. If the court upholds the DOT’s decision, Delta and Aeromexico may need to restructure their international operations, reshaping competition on one of the busiest air corridors in North America.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
U.S. Sanctions on Russia Could Expand as Ukraine Peace Talks Continue, Says Treasury Secretary Bessent
China Approves First Import Batch of Nvidia H200 AI Chips Amid Strategic Shift
Citigroup Faces Lawsuit Over Alleged Sexual Harassment by Top Wealth Executive
U.S. Justice Department Removes DHS Lawyer After Blunt Remarks in Minnesota Immigration Court
Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Federal Judge Rules Trump Administration Unlawfully Halted EV Charger Funding
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Federal Judge Restores Funding for Gateway Rail Tunnel Project 



